世界の注意欠陥多動性障害（ADHD）治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Attention Deficit Hyperactivity Disorder Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0503
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、109ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、注意欠陥多動性障害（ADHD）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（刺激剤、非刺激剤）、用途別市場規模（病院薬局、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・注意欠陥多動性障害（ADHD）治療の市場動向
・企業の競争状況、市場シェア
・注意欠陥多動性障害（ADHD）治療の種類別市場規模（刺激剤、非刺激剤）
・注意欠陥多動性障害（ADHD）治療の用途別市場規模（病院薬局、小売薬局）
・注意欠陥多動性障害（ADHD）治療の北米市場規模2016-2027（アメリカ、カナダ）
・注意欠陥多動性障害（ADHD）治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・注意欠陥多動性障害（ADHD）治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・注意欠陥多動性障害（ADHD）治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・注意欠陥多動性障害（ADHD）治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Takeda、Johnson & Johnson、Novartis、Eli Lilly、Tris Pharma、Neos Therapeutics、Mallinckrodt、Amneal Pharmaceuticals、Noven Pharmaceuticals、Purdue Parma）
・結論

Attention deficit hyperactivity disorder (ADHD) is a mental health disorder that can cause above-normal levels of hyperactive and impulsive behaviors.

Market Analysis and Insights: Global Attention Deficit Hyperactivity Disorder Therapeutics Market
The global Attention Deficit Hyperactivity Disorder Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Attention Deficit Hyperactivity Disorder Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Attention Deficit Hyperactivity Disorder Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Attention Deficit Hyperactivity Disorder Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Attention Deficit Hyperactivity Disorder Therapeutics market.

Global Attention Deficit Hyperactivity Disorder Therapeutics Scope and Market Size
Attention Deficit Hyperactivity Disorder Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Attention Deficit Hyperactivity Disorder Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Stimulant
Non-stimulant

Segment by Application
Hospital Pharmacy
Retail Pharmacy

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Attention Deficit Hyperactivity Disorder Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Stimulant
1.2.3 Non-stimulant
1.3 Market by Application
1.3.1 Global Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Attention Deficit Hyperactivity Disorder Therapeutics Market Perspective (2016-2027)
2.2 Attention Deficit Hyperactivity Disorder Therapeutics Growth Trends by Regions
2.2.1 Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Attention Deficit Hyperactivity Disorder Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Attention Deficit Hyperactivity Disorder Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Attention Deficit Hyperactivity Disorder Therapeutics Industry Dynamic
2.3.1 Attention Deficit Hyperactivity Disorder Therapeutics Market Trends
2.3.2 Attention Deficit Hyperactivity Disorder Therapeutics Market Drivers
2.3.3 Attention Deficit Hyperactivity Disorder Therapeutics Market Challenges
2.3.4 Attention Deficit Hyperactivity Disorder Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Attention Deficit Hyperactivity Disorder Therapeutics Players by Revenue
3.1.1 Global Top Attention Deficit Hyperactivity Disorder Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Attention Deficit Hyperactivity Disorder Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Attention Deficit Hyperactivity Disorder Therapeutics Revenue
3.4 Global Attention Deficit Hyperactivity Disorder Therapeutics Market Concentration Ratio
3.4.1 Global Attention Deficit Hyperactivity Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Attention Deficit Hyperactivity Disorder Therapeutics Revenue in 2020
3.5 Attention Deficit Hyperactivity Disorder Therapeutics Key Players Head office and Area Served
3.6 Key Players Attention Deficit Hyperactivity Disorder Therapeutics Product Solution and Service
3.7 Date of Enter into Attention Deficit Hyperactivity Disorder Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Attention Deficit Hyperactivity Disorder Therapeutics Breakdown Data by Type
4.1 Global Attention Deficit Hyperactivity Disorder Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Attention Deficit Hyperactivity Disorder Therapeutics Forecasted Market Size by Type (2022-2027)

5 Attention Deficit Hyperactivity Disorder Therapeutics Breakdown Data by Application
5.1 Global Attention Deficit Hyperactivity Disorder Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Attention Deficit Hyperactivity Disorder Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Attention Deficit Hyperactivity Disorder Therapeutics Market Size (2016-2027)
6.2 North America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type
6.2.1 North America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type (2016-2027)
6.3 North America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application
6.3.1 North America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application (2016-2027)
6.4 North America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country
6.4.1 North America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Size (2016-2027)
7.2 Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type
7.2.1 Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type (2016-2027)
7.3 Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application
7.3.1 Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application (2016-2027)
7.4 Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country
7.4.1 Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type
8.2.1 Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application
8.3.1 Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Region
8.4.1 Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Size (2016-2027)
9.2 Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type
9.2.1 Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application
9.3.1 Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country
9.4.1 Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type
10.2.1 Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application
10.3.1 Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country
10.4.1 Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Attention Deficit Hyperactivity Disorder Therapeutics Introduction
11.1.4 Takeda Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2016-2021)
11.1.5 Takeda Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder Therapeutics Introduction
11.2.4 Johnson & Johnson Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2016-2021)
11.2.5 Johnson & Johnson Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Attention Deficit Hyperactivity Disorder Therapeutics Introduction
11.3.4 Novartis Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Attention Deficit Hyperactivity Disorder Therapeutics Introduction
11.4.4 Eli Lilly Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2016-2021)
11.4.5 Eli Lilly Recent Development
11.5 Tris Pharma
11.5.1 Tris Pharma Company Details
11.5.2 Tris Pharma Business Overview
11.5.3 Tris Pharma Attention Deficit Hyperactivity Disorder Therapeutics Introduction
11.5.4 Tris Pharma Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2016-2021)
11.5.5 Tris Pharma Recent Development
11.6 Neos Therapeutics
11.6.1 Neos Therapeutics Company Details
11.6.2 Neos Therapeutics Business Overview
11.6.3 Neos Therapeutics Attention Deficit Hyperactivity Disorder Therapeutics Introduction
11.6.4 Neos Therapeutics Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2016-2021)
11.6.5 Neos Therapeutics Recent Development
11.7 Mallinckrodt
11.7.1 Mallinckrodt Company Details
11.7.2 Mallinckrodt Business Overview
11.7.3 Mallinckrodt Attention Deficit Hyperactivity Disorder Therapeutics Introduction
11.7.4 Mallinckrodt Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2016-2021)
11.7.5 Mallinckrodt Recent Development
11.8 Amneal Pharmaceuticals
11.8.1 Amneal Pharmaceuticals Company Details
11.8.2 Amneal Pharmaceuticals Business Overview
11.8.3 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder Therapeutics Introduction
11.8.4 Amneal Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2016-2021)
11.8.5 Amneal Pharmaceuticals Recent Development
11.9 Noven Pharmaceuticals
11.9.1 Noven Pharmaceuticals Company Details
11.9.2 Noven Pharmaceuticals Business Overview
11.9.3 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder Therapeutics Introduction
11.9.4 Noven Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2016-2021)
11.9.5 Noven Pharmaceuticals Recent Development
11.10 Purdue Parma
11.10.1 Purdue Parma Company Details
11.10.2 Purdue Parma Business Overview
11.10.3 Purdue Parma Attention Deficit Hyperactivity Disorder Therapeutics Introduction
11.10.4 Purdue Parma Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2016-2021)
11.10.5 Purdue Parma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Stimulant
Table 3. Key Players of Non-stimulant
Table 4. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Attention Deficit Hyperactivity Disorder Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Regions (2022-2027)
Table 10. Attention Deficit Hyperactivity Disorder Therapeutics Market Trends
Table 11. Attention Deficit Hyperactivity Disorder Therapeutics Market Drivers
Table 12. Attention Deficit Hyperactivity Disorder Therapeutics Market Challenges
Table 13. Attention Deficit Hyperactivity Disorder Therapeutics Market Restraints
Table 14. Global Attention Deficit Hyperactivity Disorder Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Attention Deficit Hyperactivity Disorder Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Attention Deficit Hyperactivity Disorder Therapeutics as of 2020)
Table 17. Ranking of Global Top Attention Deficit Hyperactivity Disorder Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Attention Deficit Hyperactivity Disorder Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Attention Deficit Hyperactivity Disorder Therapeutics Product Solution and Service
Table 21. Date of Enter into Attention Deficit Hyperactivity Disorder Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Attention Deficit Hyperactivity Disorder Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Attention Deficit Hyperactivity Disorder Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Attention Deficit Hyperactivity Disorder Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Attention Deficit Hyperactivity Disorder Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Attention Deficit Hyperactivity Disorder Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Attention Deficit Hyperactivity Disorder Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Takeda Company Details
Table 62. Takeda Business Overview
Table 63. Takeda Attention Deficit Hyperactivity Disorder Therapeutics Product
Table 64. Takeda Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 65. Takeda Recent Development
Table 66. Johnson & Johnson Company Details
Table 67. Johnson & Johnson Business Overview
Table 68. Johnson & Johnson Attention Deficit Hyperactivity Disorder Therapeutics Product
Table 69. Johnson & Johnson Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Johnson & Johnson Recent Development
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis Attention Deficit Hyperactivity Disorder Therapeutics Product
Table 74. Novartis Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Eli Lilly Company Details
Table 77. Eli Lilly Business Overview
Table 78. Eli Lilly Attention Deficit Hyperactivity Disorder Therapeutics Product
Table 79. Eli Lilly Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Eli Lilly Recent Development
Table 81. Tris Pharma Company Details
Table 82. Tris Pharma Business Overview
Table 83. Tris Pharma Attention Deficit Hyperactivity Disorder Therapeutics Product
Table 84. Tris Pharma Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Tris Pharma Recent Development
Table 86. Neos Therapeutics Company Details
Table 87. Neos Therapeutics Business Overview
Table 88. Neos Therapeutics Attention Deficit Hyperactivity Disorder Therapeutics Product
Table 89. Neos Therapeutics Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Neos Therapeutics Recent Development
Table 91. Mallinckrodt Company Details
Table 92. Mallinckrodt Business Overview
Table 93. Mallinckrodt Attention Deficit Hyperactivity Disorder Therapeutics Product
Table 94. Mallinckrodt Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Mallinckrodt Recent Development
Table 96. Amneal Pharmaceuticals Company Details
Table 97. Amneal Pharmaceuticals Business Overview
Table 98. Amneal Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Amneal Pharmaceuticals Recent Development
Table 100. Noven Pharmaceuticals Company Details
Table 101. Noven Pharmaceuticals Business Overview
Table 102. Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder Therapeutics Product
Table 103. Noven Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 104. Noven Pharmaceuticals Recent Development
Table 105. Purdue Parma Company Details
Table 106. Purdue Parma Business Overview
Table 107. Purdue Parma Attention Deficit Hyperactivity Disorder Therapeutics Product
Table 108. Purdue Parma Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 109. Purdue Parma Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Stimulant Features
Figure 3. Non-stimulant Features
Figure 4. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacy Case Studies
Figure 6. Retail Pharmacy Case Studies
Figure 7. Attention Deficit Hyperactivity Disorder Therapeutics Report Years Considered
Figure 8. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Regions: 2020 VS 2027
Figure 11. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Regions (2022-2027)
Figure 12. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Players in 2020
Figure 13. Global Top Attention Deficit Hyperactivity Disorder Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Attention Deficit Hyperactivity Disorder Therapeutics as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Attention Deficit Hyperactivity Disorder Therapeutics Revenue in 2020
Figure 15. Global Attention Deficit Hyperactivity Disorder Therapeutics Revenue Market Share by Type (2016-2021)
Figure 16. Global Attention Deficit Hyperactivity Disorder Therapeutics Revenue Market Share by Type (2022-2027)
Figure 17. North America Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Type (2016-2027)
Figure 19. North America Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Application (2016-2027)
Figure 20. North America Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Country (2016-2027)
Figure 21. United States Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Type (2016-2027)
Figure 25. Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Application (2016-2027)
Figure 26. Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Country (2016-2027)
Figure 27. Germany Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Region (2016-2027)
Figure 37. China Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Type (2016-2027)
Figure 45. Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Application (2016-2027)
Figure 46. Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Country (2016-2027)
Figure 47. Mexico Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Country (2016-2027)
Figure 53. Turkey Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Takeda Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Therapeutics Business (2016-2021)
Figure 57. Johnson & Johnson Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Therapeutics Business (2016-2021)
Figure 58. Novartis Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Therapeutics Business (2016-2021)
Figure 59. Eli Lilly Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Therapeutics Business (2016-2021)
Figure 60. Tris Pharma Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Therapeutics Business (2016-2021)
Figure 61. Neos Therapeutics Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Therapeutics Business (2016-2021)
Figure 62. Mallinckrodt Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Therapeutics Business (2016-2021)
Figure 63. Amneal Pharmaceuticals Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Therapeutics Business (2016-2021)
Figure 64. Noven Pharmaceuticals Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Therapeutics Business (2016-2021)
Figure 65. Purdue Parma Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Therapeutics Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z0504 2021年4月 95Pages
QYResearch社発行の本調査資料では、注意欠陥多動性障害（ADHD）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（刺激剤、非刺激剤）、用途別市場規模（専門クリニック、病院薬局、小売薬局、Eコマース）、主要地域別市場規模（北米、アメリ...

世界の注意欠陥多動性障害（ADHD）市場規模・現状・予測（2021年-2027年）

Global Attention Deficit Hyperactivity Disorder Market Size, Status and Forecast 2021-2027
QYR2104Z0502 2021年4月 97Pages
QYResearch社発行の本調査資料では、注意欠陥多動性障害（ADHD）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（刺激剤、非刺激剤）、用途別市場規模（小児、青年、成人）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の注意欠陥多動性障害（ADHD）市場規模・現状・予測（2021年-2027年）

Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size, Status and Forecast 2021-2027
QYR2104Z0501 2021年4月 98Pages
QYResearch社発行の本調査資料では、注意欠陥多動性障害（ADHD）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（刺激剤、非刺激剤）、用途別市場規模（病院薬局、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中...

世界の注意欠陥多動性障害（ADHD）市場規模・現状・予測（2021年-2027年）

世界の自閉症スペクトラム障害（ASD）診断・治療市場規模・現状・予測（2021年-2027年）

Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z0512 2021年4月 95Pages
QYResearch社発行の本調査資料では、自閉症スペクトラム障害（ASD）診断・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（自閉症、アスペルガー症候群、小児期崩壊性障害、その他）、用途別市場規模（子供・十代、成人）、主要地域別市場規模...

世界の自閉症スペクトラム障害（ASD）治療市場規模・現状・予測（2021年-2027年）

Global Autism Spectrum Disorder (ASD) Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0511 2021年4月 98Pages
QYResearch社発行の本調査資料では、自閉症スペクトラム障害（ASD）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（応用行動分析（ABA）、離散試験トレーニング（DTT）、ピボット応答トレーニング（PRT）、その他）、用途別市場規模...

世界の自閉症障害・治療市場規模・現状・予測（2021年-2027年）

Global Autism Disorder and Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0510 2021年4月 92Pages
QYResearch社発行の本調査資料では、自閉症障害・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（低機能自閉症、高機能自閉症）、用途別市場規模（1〜14歳、15〜25歳、26〜40歳、40歳以上）、主要地域別市場規模（北米、アメリカ、...

世界の自閉症障害・治療市場規模・現状・予測（2021年-2027年）

世界の全般性不安障害治療市場規模・現状・予測（2021年-2027年）

Global General Anxiety Disorder Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z2524 2021年4月 92Pages
QYResearch社発行の本調査資料では、全般性不安障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（イトリグルミド、テダチオキセチン、EDG-004、その他）、用途別市場規模（クリニック、病院、その他）、主要地域別市場規模（北米、アメ...

世界の心的外傷後ストレス障害（PTSD）治療薬市場規模・現状・予測（2021年-2027年）

Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z4715 2021年4月 99Pages
QYResearch社発行の本調査資料では、心的外傷後ストレス障害（PTSD）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗うつ薬、抗不安薬）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界の注意欠陥多動性障害（ADHD）市場規模・現状・予測（2021年-2027年） Effective treatment of ADHD. ADHD refers to a group of syndromes that occur in childhood and are characterized by obvious difficulty in concentration, short duration of attention, hyperactivity or impulsivity compared with children of the same age. There are two main types of drugs used to treat ADH…
世界の注意欠陥多動性障害（ADHD）市場規模・現状・予測（2021年-2027年） Effective treatment of ADHD. ADHD refers to a group of syndromes that occur in childhood and are characterized by obvious difficulty in concentration, short duration of attention, hyperactivity or impulsivity compared with children of the same age. There are two main types of drugs used to treat ADH…
世界の注意欠陥多動性障害（ADHD）治療市場規模・現状・予測（2021年-2027年） ADHD is a brain/neurodevelopmental/neurobehavioral disorder characterized by pervasive and impairing symptoms of inattention, hyperactivity, and impulsivity. The Centers for Disease Control and Prevention (CDC) defines “neurobehavioral” as the way the brain affects emotion, behavior, and learning. G…
世界の注意欠陥多動性障害（ADHD）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Attention Deficit Hyperactivity Disorder Market The global Attention Deficit Hyperactivity Disorder market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analys…
世界の心的外傷後ストレス障害（PTSD）治療薬市場規模・現状・予測（2021年-2027年） Post-Traumatic Stress Disorder (PTSD) therapeutics include drugs that are used in the treatment of PTSD. The rising prevalence of PTSD to be one of the primary growth factors for the post-traumatic stress disorder (PTSD) therapeutics market. Market Analysis and Insights: Global Post-Traumatic Stress…